NCT04595955View on ClinicalTrials.gov

Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life

NACompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
NeoplasmsChronic Myeloid LeukemiaPatient PortalsTelemedicine
Interventions
OTHER

CMyLife

CMyLife is a digital patient platform for Patients With Chronic Myeloid Leukemia.

Trial Locations (1)

6525 GA

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT04595955 - Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life | Biotech Hunter | Biotech Hunter